ADMA Biologics, Inc. (ADMA)

ADMA Biologics Revenue

In the year 2024, ADMA Biologics had annual revenue of $426.45M with 65.15% growth. ADMA Biologics had revenue of $117.55M in the quarter ending December 31, 2024, with 59.06% growth.

• Revenue (ttm): $426.45M
• Revenue Growth: +65.15%
• P/S Ratio: 12.20
• Revenue / Employee: $622,561
• Employees: 685
• Market Cap: 5.17B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	426.45M	168.24M	65.15%
Dec 31, 2023	258.22M	104.13M	67.59%
Dec 31, 2022	154.08M	73.14M	90.36%
Dec 31, 2021	80.94M	38.72M	91.72%
Dec 31, 2020	42.22M	12.87M	43.85%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.